Tag: dipeptidyl peptidase-4 inhibitor

1. Early combination therapy with vildagliptin and metformin is associated with improved glycemic durability in the setting of newly diagnosed type 2 diabetes. Evidence Rating Level: 1 (Excellent) Early glycemic control in type 2 diabetes is associated with glycemic durability and a reduced risk of developing related complications. The early introduction...